Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

Resources > Guideline Archive > Withdrawn NGC Summaries

Withdrawn NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been withdrawn from the NGC Web site. Select "All" to see a complete list of withdrawn NGC Guideline Summaries (organized alphabetically by guideline developer). For a list of guidelines that have been updated, go to Updated NGC Summaries.

Guideline summaries are removed from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

Note to PC users: If you are not sure which developer you need, consider using the "Find" option under the Edit menu or select Control-F to search the complete list by keyword.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1389 guidelines in the withdrawn archive.

National Academy of Clinical Biochemistry

  1. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (NGC-2747)
    • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002 Mar;48(3):436-72. [267 references] PubMed

  2. Laboratory support for the diagnosis and monitoring of thyroid disease. (NGC-2748)
    • National Academy of Clinical Biochemistry (NACB). NACB: laboratory support for the diagnosis and monitoring of thyroid disease. Washington (DC): National Academy of Clinical Biochemistry (NACB); 2002. 125 p. [495 references]

  3. Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. (NGC-4872)
    • Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 2003 Mar;49(3):357-79. [118 references] PubMed

National Anemia Action Council

  1. Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations. (NGC-5320)
    • Dubois RW, Goodnough LT, Ershler WB, Van Winkle L, Nissenson AR. Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations. Curr Med Res Opin 2006 Feb;22(2):385-95. [56 references] PubMed

For more information, please refer to the National Anemia Action Council Web site.

National Association of Neonatal Nurses

  1. Apnea of prematurity. (NGC-1373)
    • National Association of Neonatal Nurses. Apnea of prematurity. Glenview (IL): National Association of Neonatal Nurses; 1999. 22 p. [43 references]

  2. Care of the neonate requiring parenteral nutrition. (NGC-1370)
    • National Association of Neonatal Nurses. Care of the neonate requiring parenteral nutrition. Glenview (IL): National Association of Neonatal Nurses; 1999. 34 p. [13 references]

  3. Care of the premature infant with a patent ductus arteriosus. (NGC-1372)
    • National Association of Neonatal Nurses. Care of the premature infant with a patent ductus arteriosus. Glenview (IL): National Association of Neonatal Nurses; 1999. 21 p. [16 references]

  4. Discharge guidelines for the technology dependent infant. (NGC-1371)
    • National Association of Neonatal Nurses. Discharge guidelines for the technology dependent infant. Glenview (IL): National Association of Neonatal Nurses; 1999. 7 p. [31 references]

  5. Early discharge of the term newborn. (NGC-1374)
    • National Association of Neonatal Nurses. Early discharge of the term newborn. Glenview (IL): National Association of Neonatal Nurses; 1999. 33 p. [48 references]

  6. Infant and family-centered developmental care. (NGC-1419)
    • National Association of Neonatal Nurses. Infant and family-centered developmental care. Glenview (IL): National Association Neonatal Nurses; 2000. 20 p. [84 references]

For more information, please refer to the National Association of Neonatal Nurses Web site.

National Cancer Institute

  1. Adjuvant therapy for breast cancer. (NGC-1941)
    • Adjuvant therapy for breast cancer. NIH Consens Statement Online 2000 Nov 1-3;17(4):1-23. [2230 references]

National Collaborating Centre for Acute Care

  1. Head injury: triage, assessment, investigation and early management of head injury in infants, children and adults. (NGC-3551)
    • National Collaborating Centre for Acute Care. Head injury: triage, assessment, investigation and early management of head injury in infants, children and adults. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 248 p. [373 references]

  2. Preoperative tests: the use of routine preoperative tests for elective surgery: evidence, methods, & guidance. (NGC-3552)
    • National Collaborating Centre for Acute Care. Preoperative tests: the use of routine preoperative tests for elective surgery: evidence, methods & guidance. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 108 p. [118 references]

National Collaborating Centre for Chronic Conditions

  1. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. (NGC-3549)
    • National Collaborating Centre for Chronic Conditions. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. London: National Institute for Clinical Excellence (NICE); 2003. 163 p. [347 references]

National Collaborating Centre for Mental Health

  1. Depression: management of depression in primary and secondary care. (NGC-3999)
    • National Collaborating Centre for Mental Health. Depression: management of depression in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2004. 670 p. [634 references]

  2. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. (NGC-3554)
    • National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2002. 243 p. [262 references]

National Collaborating Centre for Nursing and Supportive Care

  1. Infection control. Prevention of healthcare-associated infection in primary and community care. (NGC-3553)
    • National Collaborating Centre for Nursing and Supportive Care. Infection control. Prevention of healthcare-associated infections in primary and community care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jun. 257 p. [292 references]

  2. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. (NGC-3548)
    • National Collaborating Centre for Nursing and Supportive Care. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 126 p.

National Collaborating Centre for Primary Care

  1. Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. (NGC-3733)
    • National Collaborating Centre for Primary Care. Clinical guidelines for the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. London (UK): National Institute for Clinical Excellence (NICE); 2004 May. 311 p. [309 references]

  2. Clinical guidelines for the management of anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. (NGC-4008)
    • McIntosh A, Cohen A, Turnbull N, Esmonde L, Dennis P, Eatock J, Feetam C, Hague J, Hughes I, Kelly J, Kosky N, Lear G, Owens L, Ratcliffe J, Salkovskis P. Clinical guidelines for the management of anxiety. Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. London (UK): National Institute for Clinical Excellence (NICE); 2004 Dec. 165 p. [151 references]

National Collaborating Centre for Women's and Children's Health

  1. Antenatal care: routine care for the healthy pregnant woman. (NGC-3470)
    • National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. London: RCOG Press; 2003 Oct. 286 p. [631 references]

National Environmental Education Foundation, Inc.

  1. National pesticide practice skills guidelines for medical & nursing practice. (NGC-3533)
    • National Environmental Education & Training Foundation (NEETF). National pesticide practice skills guidelines for medical & nursing practice. Washington (DC): National Environmental Education & Training Foundation (NEETF); 2003 Jan. 76 p. [15 references]

National Heart Foundation of New Zealand

  1. A guideline for the management of heart failure. (NGC-2535)
    • National Heart Foundation of New Zealand. A guideline for the management of heart failure: health professionals guide. Auckland (New Zealand): National Heart Foundation of New Zealand; 2001 Dec. 30 p. [44 references]

National Heart, Lung, and Blood Institute (U.S.)

  1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. (NGC-0660)

    • National High Blood Pressure Education Program Working Group report on hypertension in diabetes. (NGC-0594)
      • National High Blood Pressure Education Program, Working Group on Hypertension in Diabetes. National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1995 Apr. 26 p.

    • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. (NGC-0595)
      • National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994 Mar;23(3):275-85. [49 references]

    • National High Blood Pressure Education Program: Working Group report on high blood pressure in pregnancy. (NGC-0704)
      • National Heart Lung and Blood Institute. National High Blood Pressure Education Program: Working Group Report on High Blood Pressure in Pregnancy. Bethesda (MD): National Heart, Lung and Blood Institute (NHLBI); 2000 Jul. 38 p. [201 references]

    • Primary prevention of hypertension. Clinical and public health advisory from the National High Blood Pressure Education Program. (NGC-2708)
      • Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002 Oct 16;288(15):1882-8. [45 references] PubMed

    • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. (NGC-0597)
      • Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992 Mar;89(3 Pt 2):525-84. [230 references]

    • Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-3450)
      • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec;42(6):1206-52. [386 references] PubMed

    • Transfusion alert: use of autologous blood. (NGC-0593)
      • Transfusion alert: use of autologous blood. Transfusion 1995 Aug;35(8):703-11. [81 references]

    For more information, please refer to the National Heart, Lung, and Blood Institute (U.S.) Web site.

    National Hospice and Palliative Care Organization

    1. Medical guidelines for determining prognosis in selected non-cancer diseases. (NGC-0626)
      • National Hospice Organization. Medical guidelines for determining prognosis in selected non-cancer diseases. Hosp J 1996;11(2):47-63. [214 references]

    For more information, please refer to the National Hospice and Palliative Care Organization Web site.

    National Institute for Health and Clinical Excellence (NICE)

    1. Etanercept and efalizumab for the treatment of adults with psoriasis. (NGC-5411)
      • National Institute for Health and Clinical Excellence (NICE). Etanercept and efalizumab for the treatment of adults with psoriasis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Jul. 35 p. (Technology appraisal guidance; no. 103).

    2. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. (NGC-5404)
      • National Institute for Clinical Excellence (NICE). Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 20 p. (Technology appraisal guidance; no. 48).

    3. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. (NGC-4911)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. London (UK): National Institute for Clinical Excellence (NICE); 2003 May. 25 p. (Technology appraisal; no. 61).

    4. Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction. (NGC-4917)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction. London (UK): National Institute for Clinical Excellence (NICE); 2002 Oct. 25 p. (Technology appraisal guidance; no. 52).

    5. Guidance on the use of electroconvulsive therapy. (NGC-4912)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of electroconvulsive therapy. London (UK): National Institute for Clinical Excellence (NICE); 2003 Apr. 36 p. (Technology appraisal; no. 59).

    6. Guidance on the use of glitazones for the treatment of type 2 diabetes. (NGC-4908)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of glitazones for the treatment of type 2 diabetes. London (UK): National Institute for Clinical Excellence (NICE); 2003 Aug. 22 p. (Technology appraisal; no. 63).

    7. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. (NGC-4918)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 24 p. (Technology appraisal guidance; no. 47).

    8. Guidance on the use of imatinib for chronic myeloid leukaemia. (NGC-5734)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of imatinib for chronic myeloid leukaemia. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 26 p. (Technology appraisal; no. 70).

    9. Guidance on the use of liquid-based cytology for cervical screening. (NGC-4808)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of liquid-based cytology for cervical screening. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 22 p. (Technology appraisal; no. 69).

    10. Guidance on the use of metal on metal hip resurfacing arthroplasty. (NGC-5400)
      • National Institute for Clinical Excellence. Guidance on the use of metal on metal hip resurfacing arthroplasty. London (UK): National Institute for Clinical Excellence (NICE); 2002. 19 p. (Technology appraisal guidance; no. 44).

    11. Guidance on the use of paclitaxel in the treatment of ovarian cancer. (NGC-4915)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of paclitaxel in the treatment of ovarian cancer. London (UK): National Institute for Clinical Excellence (NICE); 2003 Jan. 19 p. (Technology appraisal guidance; no. 55).

    12. Guidance on the use of photodynamic therapy for age-related macular degeneration. (NGC-4906)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of photodynamic therapy for age-related macular degeneration. London (UK): National Institute for Clinical Excellence (NICE); 2003 Sep. 26 p. (Technology appraisal; no. 68).

    13. Guidance on the use of ultrasound locating devices for placing central venous catheters. (NGC-4919)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of ultrasound locating devices for placing central venous catheters. London (UK): National Institute for Clinical Excellence (NICE); 2002 Sep. 21 p. (Technology appraisal guidance; no. 49).

    14. Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. (NGC-4914)
      • National Institute for Clinical Excellence (NICE). Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. London (UK): National Institute for Clinical Excellence (NICE); 2003 Feb. 30 p. (Technology appraisal guidance; no. 58).

    15. Human growth hormone (somatropin) in adults with growth hormone deficiency. (NGC-4909)
      • National Institute for Clinical Excellence (NICE). Human growth hormone (somatropin) in adults with growth hormone deficiency. London (UK): National Institute for Clinical Excellence (NICE); 2003 Aug. 34 p. (Technology appraisal; no. 64).

    16. Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). (NGC-5406)
      • National Institute for Clinical Excellence (NICE). Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years). London (UK): National Institute for Clinical Excellence (NICE); 2002 Mar. 19 p. (Technology appraisal guidance; no. 38).

    17. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. (NGC-4810)
      • National Institute for Clinical Excellence (NICE). Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. London (UK): National Institute for Clinical Excellence (NICE); 2003 Nov. 25 p. (Technology appraisal; no. 73).

    18. Rituximab for aggressive non-Hodgkin’s lymphoma. (NGC-4907)
      • National Institute for Clinical Excellence (NICE). Rituximab for aggressive non-Hodgkin's lymphoma. London (UK): National Institute for Clinical Excellence (NICE); 2003 Sep. 22 p. (Technology appraisal; no. 65).

    For more information, please refer to the National Institute for Health and Clinical Excellence (NICE) Web site.

    National Institute of Child Health and Human Development

    1. Phenylketonuria: screening and management. (NGC-1942)
      • Phenylketonuria: screening and management. NIH Consens Statement Online 2000 Oct 16-18;17(3):1-27. [3394 references]

    National Institute on Dental and Craniofacial Research

    1. Diagnosis and management of dental caries throughout life. (NGC-2018)
      • Diagnosis and management of dental caries throughout life. Bethesda MD: Office of Medical Applications of Research (OMAR); 2001 Mar 28. 24 p. [1592 references]

    National Institutes of Health (NIH) Consensus Development Panel on Antenatal Corticosteroids

    1. Antenatal corticosteroids revisited: repeat courses. (NGC-1943)
      • Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement Online 2000 Aug 17-18;17(2):1-10.

    National Institutes of Health (NIH) Consensus Development Panel on Endoscopic Retrograde Cholangiopancreatography (ERCP) for Diagnosis and Therapy

    1. Endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. (NGC-3965)
      • Endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens Statement Online 2002 Jan 14-16;19(1):1-23.

    National Institutes of Health (NIH) Consensus Development Panel on Management of Hepatitis C

    1. Management of hepatitis C: 2002. (NGC-2642)
      • National Institutes of Health (NIH). Management of hepatitis C: 2002. Rockville (MD): National Institutes of Health (NIH); 2002 Aug 26. 44 p.

    National Institutes of Health (NIH) Consensus Development Panel on Management of the Clinically Inapparent Adrenal Mass ("Incidentaloma")

    1. Management of the clinically inapparent adrenal mass (Incidentaloma). (NGC-3964)
      • Management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens Statement Online 2002 Feb 4-6;19(2):1-23.

    National Institutes of Health (NIH) Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy

    1. Osteoporosis prevention, diagnosis, and therapy. (NGC-1761)
      • Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement Online 2000 Mar 27-29;17(1):1-36.

    National Institutes of Health (NIH) Consensus Development Panel on Symptom Management in Cancer: Pain, Depression, and Fatigue

    1. Symptom management in cancer: pain, depression and fatigue. (NGC-3963)
      • Symptom management in cancer: pain, depression, and fatigue. NIH Consens Statement Online 2002 Jul 15-17;19(4):1-29.

    National Kidney Foundation

    1. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (NGC-3312)
      • National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 Oct;42(4 Suppl 3):S1-201. [664 references] PubMed

    2. Clinical practice guidelines for nutrition in chronic renal failure. (NGC-1771)
      • Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000 Jun;35(6 Suppl 2):S1-140. [428 references]

    3. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. (NGC-2418)
      • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002 Feb;39(2 Suppl 1):S1-246. [667 references] PubMed

    For more information, please refer to the National Kidney Foundation Web site.

    National Osteoporosis Foundation

    1. Health professional's guide to rehabilitation of the patient with osteoporosis. (NGC-3074)
      • National Osteoporosis Foundation. Health professional's guide to rehabilitation of the patient with osteoporosis. Washington (DC): National Osteoporosis Foundation; 2003. 31 p. [10 references]

    2. Physician's guide to prevention and treatment of osteoporosis. (NGC-3073)
      • National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation; 2003 Apr. 37 p. [14 references]

    For more information, please refer to the National Osteoporosis Foundation Web site.

    National Society of Genetic Counselors

    1. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (NGC-2500)
      • Bennett RL, Hart KA, O'Rourke E, Barranger JA, Johnson J, MacDermot KD, Pastores GM, Steiner RD, Thadhani R. Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2002 Apr;11(2):121-46. [51 references]

    2. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. (NGC-2499)
      • Bennett RL, Motulsky AG, Bittles A, Hudgins L, Uhrich S, Doyle DL, Silvey K, Scott CR, Cheng E, McGillivray B, Steiner RD, Olsen D. Genetic counseling and screening of consanguineous couples and their offspring: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2002 Apr;11(2):97-119. [74 references]

    New York State Department of Health

    1. Family issues for patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4153)
      • Family issues for patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 25-34.

    2. HIV-related hematologic manifestations in pediatrics. (NGC-3034)
      • New York State Department of Health. HIV-related hematologic manifestations in pediatrics. New York (NY): New York State Department of Health; 2003. 12 p. [14 references]

    3. Immunologic considerations in HIV-infected children. (NGC-3048)
      • New York State Department of Health. Immunologic considerations in HIV-infected children. New York (NY): New York State Department of Health; 2003 Mar. 20 p. [5 references]

    4. Neurologic complications in HIV-infected children and adolescents. (NGC-3047)
      • New York State Department of Health. Neurologic complications in HIV-infected children and adolescents. New York (NY): New York State Department of Health; 2003 Mar. 19 p. [19 references]

    5. Psychiatric/mental status evaluations in primary care settings. Mental health care for people with HIV infection. (NGC-4151)
      • Psychiatric/mental status evaluations in primary care settings. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 13-8.

    6. The role of the primary care practitioner in assessing and treating mental health in persons with HIV. Mental health care for people with HIV infection. (NGC-4150)
      • The role of the primary care practitioner in assessing and treating mental health in persons with HIV. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 1-12.

    For more information, please refer to the New York State Department of Health Web site.

    New Zealand Guidelines Group

    1. (1) Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. (2) Guideline update: hormone replacement therapy. (NGC-2333)
      • New Zealand Guidelines Group. Best practice evidence-based guideline for the appropriate prescribing of hormone replacement therapy. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2001 May. 185 p. [470 references]


      • New Zealand Guidelines Group. Hormone replacement therapy: guideline update. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Sep. 2 p.

    2. Acute management and immediate rehabilitation after hip fracture amongst people aged 65 years and over. (NGC-3272)
      • New Zealand Guidelines Group (NZGG). Acute management and immediate rehabilitation after hip fracture amongst people aged 65 years and over. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jun. 26 p. [60 references]

    3. Assessment processes for older people. (NGC-3274)
      • New Zealand Guidelines Group (NZGG). Assessment processes for older people. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Oct. 82 p. [211 references]

    4. Cardiac rehabilitation. (NGC-2689)
      • New Zealand Guidelines Group (NZGG). Cardiac rehabilitation. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Aug. 163 p. [379 references]

    5. Guidelines for smoking cessation: revised 2002. (NGC-2533)
      • National Advisory Committee on Health and Disability. Guidelines for smoking cessation: revised 2002. Wellington (New Zealand): National Advisory Committee on Health and Disability (National Health Committee); 2002 May. 33 p. [42 references]

    6. Guidelines for the management of uterine fibroids. (NGC-1505)
      • New Zealand Guidelines Group. Guidelines for the management of uterine fibroids. Wellington (NZ): New Zealand Guidelines Group (NZGG); 1999 Aug. 120 p. [182 references]

    7. Life after stroke. New Zealand guideline for management of stroke. (NGC-3364)
      • New Zealand Guidelines Group (NZGG). Life after stroke. New Zealand guideline for management of stroke. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Nov. 84 p. [164 references]

    8. Management of type 2 diabetes. (NGC-3363)
      • New Zealand Guidelines Group (NZGG). Management of type 2 diabetes. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Dec. 143 p. [565 references]

    9. Prevention of hip fracture amongst people aged 65 years and over. (NGC-3271)
      • New Zealand Guidelines Group (NZGG). Prevention of hip fracture amongst people aged 65 years and over. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jun. 31 p. [54 references]

    10. The assessment and management of cardiovascular risk. (NGC-3362)
      • New Zealand Guidelines Group (NZGG). The assessment and management of cardiovascular risk. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Dec. 190 p. [705 references]

    11. The assessment and management of people at risk of suicide. (NGC-3273)
      • New Zealand Guidelines Group (NZGG). The assessment and management of people at risk of suicide. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 May. 72 p. [89 references]

    12. The diagnosis and management of soft tissue knee injuries: internal derangements. (NGC-3270)
      • New Zealand Guidelines Group (NZGG). The diagnosis and management of soft tissue knee injuries: internal derangements. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2003 Jul. 100 p. [229 references]

    13. The diagnosis and treatment of adult asthma. (NGC-2688)
      • New Zealand Guidelines Group (NZGG). The diagnosis and treatment of adult asthma. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2002 Sep. 101 p. [129 references]

    For more information, please refer to the New Zealand Guidelines Group Web site.

    New Zealand National Health Committee

    1. Guidelines for the management of heavy menstrual bleeding. (NGC-1410)
      • New Zealand Guidelines Group. An evidence-based guideline for the management of heavy menstrual bleeding. Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. N Z Med J 1999 May 28;112(1088):174-7. PubMed

    Newcastle Guideline Development and Research Unit

    1. Dyspepsia: managing dyspepsia in adults in primary care. (NGC-3795)
      • North of England Dyspepsia Guideline Development Group. Dyspepsia: managing dyspepsia in adults in primary care. Newcastle upon Tyne (UK): Centre for Health Services Research, University of Newcastle; 2004 Aug. 228 p. [466 references]

    2. Essential hypertension: managing adult patients in primary care. (NGC-3796)
      • North of England Hypertension Guideline Development Group. Essential hypertension: managing adult patients in primary care. Newcastle upon Tyne (UK): Centre for Health Services Research, University of Newcastle; 2004 Aug. 261 p. [558 references]

    North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

    1. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children. (NGC-2819)
      • Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, Gerson WT, Werlin SL. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32(Suppl 2):S1-31. [336 references] PubMed

    2. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. (NGC-2820)
      • Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, Macarthur C, Snyder J, Sherman PM. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000 Nov;31(5):490-7. [64 references] PubMed

    North American Spine Society

    1. Herniated disc. In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2029)
      • North American Spine Society. Herniated disc. LaGrange (IL): North American Spine Society (NASS); 2000. 104 p. [205 references]

    2. Spondylolysis, lytic spondylolisthesis and degenerative spondylolisthesis (SLD). In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2030)
      • North American Spine Society. Spondylolysis, lytic spondylolisthesis and degenerative spondylolisthesis (SLD). LaGrange (IL): North American Spine Society (NASS); 2000. 106 p. [241 references]

    3. Unremitting low back pain. In: North American Spine Society phase III clinical guidelines for multidisciplinary spine care specialists. (NGC-2031)
      • North American Spine Society. Unremitting low back pain. LaGrange (IL): North American Spine Society (NASS); 2000. 96 p. [204 references]

    Nutrition Screening Initiative

    1. Cancer. Nutrition management for older adults. (NGC-3231)
      • Barrocas A, Purdy D, Brady P, Troutman D. Cancer. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 19 p. [28 references]

    2. Chronic obstructive pulmonary disease. Nutrition management for older adults. (NGC-3233)
      • Harmon-Weiss S. Chronic obstructive pulmonary disease. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 11 p. [38 references]

    3. Congestive heart failure. Nutrition management for older adults. (NGC-3232)
      • Tangalos EG. Congestive heart failure. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 12 p. [30 references]

    4. Coronary heart disease. Nutrition management for older adults. (NGC-3230)
      • Verderose J. Coronary heart disease. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 15 p. [34 references]

    5. Dementia. Nutrition management for older adults. (NGC-3234)
      • Ham R. Dementia. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 10 p. [45 references]

    6. Diabetes mellitus. Nutrition management for older adults. (NGC-3235)
      • White JV. Diabetes mellitus. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 14 p. [22 references]

    7. Osteoporosis. Nutrition management for older adults. (NGC-3236)
      • Dwyer J. Osteoporosis. Nutrition management for older adults. Washington (DC): Nutrition Screening Initiative (NSI); 2002. 22 p. [50 references]




    Search Help
    Detailed Search
    Frequent Searches

    Resources

    » Annotated Bibliographies
    » Discussion List
    » AHRQ Evidence Reports
    » FAQ
    » Glossary
    » Guideline Resources
    » Hospital Acquired Conditions
    » New Features
    » NLM Links
    » Patient Resources
    » PDA/Palm
    » RSS Feeds
    » Search Form